Study Stopped
No enrollment
Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures
A Pilot Study of Vertebral Augmentation With Kyphoplasty Versus Nonsurgical Management in Multiple Myeloma Patients With Mildly Symptomatic Vertebral Body Compression Fractures
2 other identifiers
interventional
N/A
0 countries
N/A
Brief Summary
The purpose of this study is to find out how balloon kyphoplasty (surgical repair of the patient's fracture using balloons and bone cement) compares to non-surgical treatment in reducing vertebral compression fractures while providing pain relief and improved function and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2010
Shorter than P25 for not_applicable multiple-myeloma
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 3, 2010
CompletedFirst Posted
Study publicly available on registry
August 4, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedJanuary 12, 2012
January 1, 2012
10 months
August 3, 2010
January 11, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Time to Vertebral Event
Time to vertebral event (composite end point of pain progression, hospitalization for pain, and rescue vertebral augmentation or surgery or radiation therapy as related to an index fracture)
Average of 12 months
Time to Pain Progression
Time to pain progression defined as the time to the development of pain severity rated greater than 4 on the visual analog scale (VAS) as related to an index fracture
Average of 12 months
Secondary Outcomes (7)
Rate of Vertebral Events
12 months
Rate of Hospitalization
12 months
Complications of Procedure
Average of 12 months
Quality of Life Questionnaire Results
Average of 12 months
Changes in Pulmonary Function
Average of 12 months
- +2 more secondary outcomes
Study Arms (3)
Observation Arm
NO INTERVENTIONPatients who are asymptomatic (no symptoms) will participate in the observational portion of the study.
Balloon Kypholasty
EXPERIMENTALControl Arm
ACTIVE COMPARATORNon-surgical Management Treatment Group
Interventions
Two small metal tubes will be inserted through the skin into the collapsed bone. Inflatable bone tamps (balloon catheters) will be inserted through each of these two tubes into the bone. The balloons will be inflated with a liquid that can be seen on xrays (contrast) to return the bone toward its natural shape and create a cavity. The balloons will then be deflated and removed. The cavity in the bone will be filled with bone cement to stabilize the broken backbone.
Non-surgical treatment means the institution of therapies other than cancer chemotherapy and surgical treatment aimed at alleviation of back pain and restoration of decreased function associated with the patient's VCF(s).
Eligibility Criteria
You may qualify if:
- Patients with multiple myeloma (active or smoldering) with mild back pain (Visual Analog Scale \[VAS\]) ≤ 4 or no back pain (VAS=0) on a stable analgesic regimen) related to vertebral compression fractures (at least one and up to 8 index fractures from T3 to L5) as seen on magnetic resonancy imaging (MRI), computed axial tomography (CT) scan or plain radiographs.
- No major planned spine surgery for at least 6 months following enrollment.
- No evidence of epidural disease or cord compromise on magnetic resonance imaging.
- Life expectancy greater than 6 months.
- Adequate myeloma systemic control (no evidence of active progressive disease). No planned change in chemotherapy regimen for 1 month prior and for at least 1 month following enrollment. Change in dose(s) permitted.
- Adequate hematologic parameters (platelet count≥50,000/μL, and absolute neutrophil count ≥1,000). Platelet transfusions are permitted to increase platelet counts perioperatively.
- Age greater than 21 years and able to understand and sign the informed consent document.
You may not qualify if:
- Patients with significant comorbidities (aside from the index fracture or cancer) which would result in an unacceptable surgical risk or patients with contraindications to general or local anesthesia.
- Patients with other primary tumors including primary bone tumors or solitary plasmacytoma at site of the index VCF.
- VCF morphology deemed unsuitable for balloon kyphoplasty (vertebra planum).
- Additional non-kyphoplasty surgical treatment is required for the index fracture.
- Patients with uncontrolled pain related to the VCF (VAS\>4, or increasing opioid requirements), or with epidural disease on magnetic resonance imaging. Spinal cord compression , canal compromise and /or spinal instability requiring decompression.
- Patients with a bleeding disorder which cannot be adequately managed perioperatively.
- Patients with pain unrelated to the VCF according to the investigators.
- Patients with estimated survival less than 6 months.
- Known allergy to bone cement or all contrast media used in the treatment of study participants.
- MRI contraindication (e.g., cerebral aneurysm clips, pacemaker, implanted biostimulators, cochlear implants, penile prosthesis).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frank Vrionis, M.D.
H. Lee Moffitt Cancer Center and Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 3, 2010
First Posted
August 4, 2010
Study Start
July 1, 2010
Primary Completion
May 1, 2011
Study Completion
May 1, 2011
Last Updated
January 12, 2012
Record last verified: 2012-01